Cargando…
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
This systematic review examines current randomized clinical trials of therapeutic agents to treat coronavirus disease 2019 (COVID-19).
Autores principales: | Kouzy, Ramez, Abi Jaoude, Joseph, Garcia Garcia, Carolina J., El Alam, Molly B., Taniguchi, Cullen M., Ludmir, Ethan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358910/ https://www.ncbi.nlm.nih.gov/pubmed/32658285 http://dx.doi.org/10.1001/jamanetworkopen.2020.15100 |
Ejemplares similares
-
Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Exclusion of Older Adults in COVID-19 Clinical Trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2020) -
Cancer Research after COVID-19: Where Do We Go from Here?
por: Colbert, Lauren E., et al.
Publicado: (2020) -
Applying to Radiation Oncology Amid a Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Impact factor and citation metrics in phase III cancer trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)